Aerie Pharmaceuticals, Inc. (AERI) financial statements (2020 and earlier)

Company profile

Business Address 4301 EMPEROR BOULEVARD
DURHAM, NC 27703
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments30920325023413714070
Cash and cash equivalents144203198198918670
Short-term investments165 52364654 
Receivables383     
Inventory, net of allowances, customer advances and progress billings2110    
Inventory2110     
Other undisclosed current assets8544211
Total current assets:37622025423813814170
Noncurrent Assets
Operating lease, right-of-use asset17
Property, plant and equipment5861328400
Long-term investments and receivables    1418 
Long-term investments    1418 
Other noncurrent assets2443320
Total noncurrent assets:7665361121200
TOTAL ASSETS:45328529024815916170
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities78512310556
Accounts payable131266221
Accrued liabilities65389    
Employee-related liabilities  84321
Interest and dividends payable   111 
Accounts payable and other accrued liabilities3
Debt6      
Other undisclosed current liabilities  29124(2)
Total current liabilities:845125191793
Noncurrent Liabilities
Long-term debt and lease obligation201 124124123124 
Long-term debt, excluding current maturities189 124124123124 
Operating lease, liability12
Liabilities, other than long-term debt166    
Other liabilities166    
Total noncurrent liabilities:2026129124123124 
Total liabilities:286571551431401333
Stockholders' equity
Stockholders' equity attributable to parent167228136105192867
Common stock0000000
Additional paid in capital1,063924597422236171162
Accumulated other comprehensive loss(0) (0)(0)(0)(0) 
Accumulated deficit(896)(696)(462)(317)(218)(143)(95)
Total stockholders' equity:167228136105192867
TOTAL LIABILITIES AND EQUITY:45328529024815916170

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues7024     
Cost of revenue(28)(27)     
Cost of goods and services sold(23)(1)     
Other cost of operating revenue(5)      
Gross profit:42(3)     
Operating expenses(230)(207)(146)(97)(75)(50)(22)
Operating loss:(187)(210)(146)(97)(75)(50)(22)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(12)(23)(1)(2)12(9)
Interest and debt expense(15) (0)(3)(2)(1)(7)
Loss from continuing operations before equity method investments, income taxes:(215)(233)(147)(101)(77)(49)(38)
Other undisclosed income from continuing operations before income taxes15 032  
Loss from continuing operations before income taxes:(200)(233)(147)(99)(74)(49)(38)
Income tax expense (benefit)0(0)2(0)(0)  
Net loss:(200)(233)(145)(99)(74)(49)(38)
Other undisclosed net income attributable to parent     17
Net loss attributable to parent:(200)(233)(145)(99)(74)(48)(31)
Preferred stock dividends and other adjustments      (0)
Other undisclosed net loss available to common stockholders, basic      (0)
Net loss available to common stockholders, diluted:(200)(233)(145)(99)(74)(48)(32)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(200)(233)(145)(99)(74)(49)(38)
Other comprehensive loss   (99)(74)(48)(31)
Comprehensive loss:(200)(233)(145)(198)(149)(97)(69)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)00    
Comprehensive loss, net of tax, attributable to parent:(200)(233)(145)(198)(149)(97)(69)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: